In this research, we discovered that ALG3 is capable of efficiently activating all 6 distinct kinds of immune cells (neutrophils, CD8+ T cells, macrophages, CD4+ T cells, dendritic cells, and B cells) in approximately 20 different types of cancer. The gene discussed is CD8A; the disease is cancer.